Podcasts about unitedhealth

Why UnitedHealth's Criminal Investigation Is Fueling the Cash Practice Movement In this episode, Danny, founder of PT Biz, exposes the major criminal investigation into UnitedHealth and breaks down how their alleged Medicare Advantage fraud is creating the perfect storm for the rise of cash-based healthcare. With the Department of Justice involved and billions of taxpayer dollars at stake, this could be one of the biggest health insurance scandals of our time. More importantly, Danny explains how this chaos is a massive opportunity for providers who want to ditch the insurance system and build profitable, transparent, patient-first practices outside the traditional model. Topics Covered Why UnitedHealth is being criminally investigated by the DOJ How Medicare Advantage "upcoding" works—and why it's fraud Why more people are abandoning traditional insurance plans The connection between high deductibles and patient behavior How cash-based and out-of-network clinics are thriving in the mess The mindset shift from sick care to proactive health investment Why this is the best time to start or scale a cash-based clinic Common fears about market saturation—and why they're unfounded Key Quote “People used to think I was a jackass for not taking insurance. Now they're looking for clinics like this on purpose.” Resources & Links Visit PT Biz – See how we help cash-based and hybrid practices grow Book a Free Strategy Call – Speak with our team and get clear on your next steps Subscribe on YouTube – Get breakdowns, insights, and client case studies Read the PT Biz Book – Learn how to build your own cash-based practice Final Thought The system is broken—and people know it. With trust in insurance companies at an all-time low, more patients are seeking alternatives that put their health and dollars first. If you've ever considered going cash-based or out-of-network, there's never been a better time to start.

Eden Prairie-based UnitedHealth Group is suing the international news organization, The Guardian, for defamation. The Guardian article in question explores how UnitedHealth engaged in cost-cutting tactics by paying off nurses to cut down on hospital transfers. The Guardian cited internal emails, documents and interviews with more than 20 current and former staffers.But the health insurance company claims the paper ran information it knew to be incorrect to capitalize on the killing of CEO Brian Thompson. Jane Kirtley, a professor of media law and ethics at the University of Minnesota, broke down the lawsuit on Minnesota Now.

Thu, 12 Jun 2025 13:30:00 +0000 https://bxtv.podigee.io/434-neue-episode 68e3b5ed9b1cb826640ed12c960b281b Abgestürzte Blue Chip Aktien - Wall Street Live mit Tim Schäfer Tim Schäfer live aus New York – dieses Mal mit einem spannenden Blick auf abgestürzte Blue-Chip-Aktien, bei denen sich ein Einstieg lohnen könnte. Gemeinsam mit David Kunz analysiert Tim prominente Verlierer der letzten Monate, die möglicherweise vor einer Erholung stehen. In unserem zweiwöchigen Format „Wall Street Live“ mit Tim Schäfer, Finanzredakteur und Blogger direkt von der Wall Street behandeln wir Topaktuelle Themen des Marktgeschehens. Themen im Video:

UnitedHealth is the largest healthcare company in the U.S. But over the last 18 months, a string of challenges, including several Justice Department probes, have tested the company. WSJ's Anna Wilde Mathews and Christopher Weaver report on how the company rose to prominence, why its CEO is out, and how it has weathered the setbacks. Annie Minoff hosts.   Further Listening:  -Medicare, Inc. Part 1: How Insurers Make Billions From Medicare  -Medicare, Inc. Part 2: Taxpayers Paid for Care Denied by Insurers  Sign up for WSJ's free What's News newsletter.  Learn more about your ad choices. Visit megaphone.fm/adchoices

Catacombs. A doctor demolishes UnitedHealth with a scathing email after they deny nausea meds to a pediatric cancer patient. A friend's boyfriend gives a girl a very expensive birthday present …with a twist. r/meme breaks Gabe's brain with a redo of the Gregorian calendar into a lunar calendar. r/serverlife brings us a story of an anonymous letter and the return of a ring lost at Texas Roadhouse. Then, AN ABSOLUTELY BANANAS story about a woman, her husband, her husband's female best friend and a photoshoot. And finally, science tells us if human and plant DNA can mix.Check out all of our content on Patreon, Ad Free! Watch the full episodes of TLDRI, listen to the full episodes of The Variety Show, watch the International Question and Topix videos, join us for a monthly livestream, PLUS MORE:https://www.patreon.com/justbetweenusThis has been a Gallison ProductionProduced by Melisa D. Monts and Diamond MPrint ProductionsPost-Production by Coco LlorensProduction Assistance by Melanie D. WatsonOur Sponsors:* Check out Happy Mammoth and use my code JUSTBETWEENUS for 15% off!* Check out Rosetta Stone and use my code TODAY for a great deal: https://www.rosettastone.comSupport this podcast at — https://redcircle.com/just-between-us/donationsAdvertising Inquiries: https://redcircle.com/brandsPrivacy & Opt-Out: https://redcircle.com/privacy

Some of the sickest Medicare Advantage patients ran into problems getting end-of-life care. Ultimately many patients switched to traditional Medicare, costing taxpayers billions, according to an investigation by the Wall Street Journal. This is one of many Medicare Advantage practices that is now under government scrutiny. Both Congress and Medicare agency head Dr. Mehmet Oz are pushing for reforms to curb tactics that can boost federal payments to private insurers. The Department of Justice is also investigating major private insurance companies UnitedHealth, Aetna, Elevance Health and Humana. Jessica Mendoza discusses the investigations with WSJ's Anna Wilde Mathews. Further Listening: -Medicare, Inc. Part 1: How Insurers Make Billions From Medicare  -A Life-or-Death Insurance Denial  Sign up for WSJ's free What's News newsletter. Learn more about your ad choices. Visit megaphone.fm/adchoices

Story of the Week (DR):The Baby Billionaire Bromance is Over: Savannah Guthrie Says Elon Musk and Donald Trump Are 'Giving 7th Grade Girl' as President Says Tesla CEO 'Has Lost His Mind'"It's so confusing isn't it? So much going wrong, so much to say, and all of it happening so quickly. The pace of oppression outstrips our ability to understand it. And that is the real trick of the Imperial thought machine.”BlackRock removed from Texas boycott list after quitting climate groupsIn a notable reversal, Texas removed BlackRock from its investment blacklistThis decision followed BlackRock's withdrawal from several climate-focused initiatives, including the Net Zero Asset Managers alliance and Climate Action 100+Texas Comptroller Glenn Hegar cited these actions, along with BlackRock's support for the new Texas Stock Exchange, as reasons for the delisting.“More than $4 billion in Texas funds are invested with BlackRock,” the rep said.The Larry Fink-led company had $11.55 trillion in assets under management at the end of the fourth quarter in 2024.0.0346% Is that possible?Larry Fink; $31M; $11M bonus: “These amounts represent the discretionary annual cash Bonuses … The amount of incentive compensation awarded … was based on subjective criteria”“Lead in a changing world: Completed the creation of a more modern and unified Corporate Affairs function and leveraged the function to refresh the firm's corporate narrative and strengthen its brand.”“Corporate sustainability: Achieved BlackRock's 100% renewable electricity match goal and enhanced the Company's approach to procuring market solutions.”32% said NO on Pay (BlackRock owns 6% of BlackRock)99% said NO to Bowyer Research's theatrical request for a report on “risks related to a perceived shift away from a traditional understanding of fiduciary responsibility to stakeholder capitalism, implied by its assent to the Business Roundtable's Statement on the Purpose of a Corporation, as well as a high-profile embrace of ESG and DEI.”BlackRock CEO Larry Fink has some words of wisdom for leaders navigating the age of populism and social media: Watch what you say: "You have to be a lot more guarded. I can't say everything I really want to say to all of you right now. The reality is you have to be a lot more systematic in what you say and how you say it internally or externally. I mean, we live in a terrarium today. We live in a glass bottle."Big brands are pulling back on Pride merchandise and events this year MMCorporate America Pulls Back from PRIDE in 2025, No Rainbow Logos from Big Brands as June StartsUnitedHealth Group AGM:94% average director support93% Stephen HemsleyHemsley is stepping forward to acknowledge the fallout and chart a new course, promising a comprehensive review of some of the company's most controversial practices.The Wall Street Journal noted in its report on the company's annual shareholder meeting on Monday that Hemsley apologized for UnitedHealth's recent performance and cited a need to rethink many internal processes.99% for directors like Paul Garcia (2021/ former CEO of Global Payments) and Kristen Gil (2022/former VP, Business Finance Officer at Alphabet)92% for Michele Hooper (2007/Lead Independent Director/CEO of The Directors' Council, a private company she co-founded in 2003 that works with corporate boards to increase their independence, effectiveness and diversity)-12% gender influence gap/only 3 women/zero committee chairs)Lowest vote is John Noseworthy, M.D. (86%) former CEO of the Mayo Clinic40% NO on PaySHP excessive golden parachutes 13% YESThe board authorized the payment of a cash dividend of $2.21 per share, up from the prior dividend of $2.10, to be paid June 24 to common stock shareholders of record as of the close of business June 16Hemsley: as of the proxy date: $2.8M (as of 5/16: $3.8M)The previous dividend was $2.10 per share, paid on March 18, 2025The company also suspended its 2025 outlook.Goodliest of the Week (MM/DR):DR: The Trump EPA tried to bury some good newsA climate report acquired by a Freedom of Information Act request shows that U.S. climate pollution declined in 2023.The EPA report documents that in 2023, U.S. climate pollution fell by 2.3%. That's about 147 million metric tons, or MMT, of reduced carbon dioxide-equivalent greenhouse gases.2023 was the first full year after President Biden signed the Inflation Reduction Act, the Democrats' signature climate law that committed hundreds of billions of dollars to reducing climate pollution.DR: How a Peruvian farmer's legal defeat raised new risks for companies DRPeruvian farmer Saúl Luciano Lliuya filed a lawsuit against German energy company RWE, asserting that the company's greenhouse gas emissions contributed to the melting of glaciers near his hometown of Huaraz, Peru.This glacial melt increases the risk of flooding from Lake Palcacocha, threatening his community. Lliuya sought approximately $17,500 from RWE, representing 0.47% of the estimated $4 million needed for flood defenses, corresponding to RWE's estimated share of global emissions since the industrial era began. On May 28, 2025, the Higher Regional Court in Hamm, Germany, dismissed Lliuya's lawsuit. The court acknowledged the legal principle that major greenhouse gas emitters can be held liable for climate-related damages. However, it concluded that the specific threat to Lliuya's property was not sufficiently imminent to warrant compensation. While Lliuya did not secure the compensation sought, the court's recognition of potential corporate liability for climate damages sets a precedent. This acknowledgment may influence future climate litigation, encouraging individuals and communities to hold major emitters accountable for their contributions to climate change.MM: HahahahahahahahahaMusk says SpaceX will decommission Dragon spacecraft after Trump threatElon Musk Melts Down, Claims Trump Is In The "Epstein Files" and That's the Reason They Haven't Been ReleasedElon Musk Declares That He's "Immediately" Cutting Off NASA's Access to SpaceMusk Privately Complaining That His Immense Donations to Trump Didn't Even Buy Him Control of NASAElon Musk claims ‘without me, Trump would have lost the election'Assholiest of the Week (MM): Proxy advisorsZevra TherapeuticsISS added, “...the board's concerns about having a former CEO on the board and potential disruption are valid.”Out of 92,594 active directors in MSCI data from February, 3,123 are tagged as “former executives” at the company they're on the board of522 US companies are on the list - FIVE HUNDRED AND TWENTY TWOThat includes at least one company - National Healthcare Corp - with FOUR former executives on the boardIt also includes 104 large cap companies - like Hewlett Packard, with 3 former execs!Glass Lewis highlighted, “Mr. Regan has limited, dated, and unrelated public board service,”Egan-Jones also questioned the relevant expertise of Mangless' nominees, stating, “…we do not believe Mr. Regan's background in proxy solicitation offers meaningful value in the context of Zevra's boardroom.”Unrelated public board experience?? So you definitely suggested voting against Dana White at Meta? Or Peltz at Disney and his deep media experience? We look at director knowledge pulled from every bio, school, and degree we can get our hands on and standardized the knowledge types in our dataSo we know the average type of knowledge of directors in a given sector - and who DOESN'T have itOur data suggests that only 22% of directors have direct/core knowledge relevant to their industry - less than 1 in 4Shall we vote against the other 78% of directors??Glass Lewis also said that “publication of certain social media activity by Mr. Regan appears to suggest something of a blithe approach to compliance...”Elon?RobotsAmazon ‘testing humanoid robots to deliver packages'FBI says Palm Springs bombing suspects used AI chat program to help plan attackOpenAI to appeal copyright ruling in NY Times case as Altman calls for 'AI privilege'“Talking to AI should be like talking to a doctor or lawyer”Walmart plans to expand drone deliveries to three more statesWaymo's Self-Driving Taxis Have a Hilarious Problem That's Driving People BananasThey honk when backing up“Reverse discrimination” DRDismissed by DEI: Trump's Purge Made Black Women With Stable Federal Jobs an “Easy Target”Quay Crowner was among the top education officials who enrolled in the “diversity change agent program.”Crowner was abruptly placed on leave under Trump's executive order to dismantle DEI programs across the federal government.Her current job as the director of outreach, impact and engagement at the Education Department was not connected to diversity initiatives.More troubling, she said, was that she was the only person on her team who had been let go, and her bosses refused to answer her questions about her dismissal.When she and colleagues from different departments began comparing notes, they found they had one thing in common. They had all attended the training encouraged under DeVos. They also noticed something else: Most of them were Black women.“We have observed approximately 90% of the workers targeted for terminations due to a perceived association with diversity, equity and inclusion efforts are women or nonbinary,”Trump Appoints 22-Year-Old Ex-Gardener and Grocery Store Assistant to Lead U.S. Terror PreventionThe data:We don't have proxy season results in the system yet, but we do have data between August 2024 and May 2025 with results lagThe early results for US companies:54 have become “more manly” - added men, removed women95 have become “more womanly” - added women, removed menGOOD RIGHT? Or…1,163 companies had man “power ups” - men got more influence1,075 companies had female “power ups” - so men are getting fewer board seats, but more power at more companies?SECRET: expand the board and add men! 422 boards expanded between Aug and May, and 362 seats went to men and 181 to women - literally 2:1 ratio!574 US companies now have 2 or fewer women on the boards - up 8 companies between Aug and May, and results aren't even in the antiwoke Trump eraRetail investorsVOTEAccused UnitedHealthcare CEO killer Luigi Mangione said executive ‘had it coming,' prosecutors revealUnitedHealth investors approve new CEO's $60M pay package despite turmoil following top executive's assassinationUS-Boeing deal over 737 Max crashes ‘morally repugnant', says lawyer for victims' familiesLowest vote result from April for board: 92% in favor of Robert Bradway, everyone else 94% or better - including 98% in favor of OrtbergHeadliniest of the WeekDR: In light of headlines like this: Meta's Platforms Have Become a Cesspool of Hatred Against Queer People I wanted to point out this op-ed from the NYT: Anthropic C.E.O.: Don't Let A.I. Companies off the Hook Anthropic CEO Dario Amodei opposes a proposed 10-year federal ban on state AI regulation, calling it "too blunt" for the rapidly evolving technology.He argues that AI could fundamentally change the world within just a couple of years, making a decade-long freeze risky and impractical.Amodei warns the ban would leave states unable to act and the nation without a coherent federal policy, exposing the public to AI risks.He cites real-world examples of risky AI behavior, such as Anthropic's own model threatening to leak user emails, to highlight the need for oversight.Instead of a moratorium, Amodei urges Congress and the White House to establish a national transparency standard requiring AI companies to publicly disclose testing protocols, risk mitigation strategies, and safety measures before releasing new modelsMM: The maker of Taser is the highest paid CEO, taking home $165 million—his new pay package and soaring stock made him a billionaire last yearWho Won the Week?DR: The meritocracy: Meet Thomas Fugate: 22-year-old ex-gardener and grocery store assistant to lead $18 million terror prevention teamMM: After reading no fewer than 12 hours and 500 stories of the Musk/Trump feud, I've concluded this week there are no winners. We're all losers.PredictionsDR: Musk Challenges Trump to Cage Match on Mars: ‘Winner Gets X, Loser Gets Truth Social" but actually… their hatred for all things DEI/gay is too much to keep them apart, especially in the month of Pride and JuneteenthMM: The 19 analysts covering Palantir stock are given umbrellas by their respective firms after Trump may team with a tech company to create a database of Americans, just two months after CEO Alex Karp said that Wall Street analysts who "tried to screw" the company should be sprayed with "light fentanyl-laced urine" from drones.CALLBACK ALERT: Glass Lewis also said that “publication of certain social media activity by Mr. Regan appears to suggest something of a blithe approach to compliance...”

In this episode, Molly Gamble, Vice President of Editorial at Becker's Healthcare, breaks down major industry developments including UnitedHealth's defamation suit against The Guardian, looming federal coverage cuts, and Northwestern Medicine's new academic partnership with BayCare in Florida.

In this episode, Jakob Emerson, Associate News Director at Becker's Healthcare, joins Scott Becker to break down UnitedHealth's leadership shakeup and turnaround plan, as well as major CMS changes that will dramatically increase audits of Medicare Advantage plans.

This is Zack Fuss. Today, we're tackling a giant in a controversial and incredibly complex industry, UnitedHealth Group. At its recent apex, UNH was a half-trillion-dollar market cap business, the 15th largest listed business in the United States. Today, that market cap sits at just $275 billion. The company generates an excess of $400 billion in sales annually and produces $40 billion in EBITDA as it touches every facet of the American healthcare system. To break down UnitedHealthcare, I'm joined by Stephanie Niven, a co-PM of the Global Sustainable Equity Strategy within the Sustainable Equity Team at Ninety One. Stephanie has been following the company since 2012 and she helps us to unravel this intricate business. We explore how UnitedHealthcare operates as a fully integrated healthcare system from its insurance arm to its high-margin health services business. We also dive into the concept of value-based care, the recent headwinds from Medicare Advantage scrutiny, and whether the market is mispricing this complex giant amidst regulatory noise and leadership changes. Please enjoy this breakdown of UnitedHealth Group. ⁠⁠Subscribe⁠⁠ to Colossus Review For the full show notes, transcript, and links to the best content to learn more, check out the episode page⁠ ⁠here⁠⁠. —- This episode is brought to you by Octus, formerly Reorg, is the essential credit intelligence and data provider for nearly 40,000 professionals across the world's leading buy side firms, investment banks, law firms and advisory firms. By surrounding unparalleled human expertise with embedded AI technology, data and workflow tools, Octus unlocks powerful truths that fuel decisive action in financial markets. Visit⁠⁠ octus.com⁠⁠ to learn how rigorously verified intelligence is delivered at speed to create a complete picture across the entire credit lifecycle. —- Business Breakdowns is a property of Colossus, LLC. For more episodes of Business Breakdowns, visit⁠⁠ joincolossus.com/episodes⁠⁠. Editing and post-production work for this episode was provided by The Podcast Consultant (⁠⁠https://thepodcastconsultant.com⁠⁠). Show Notes (00:00:00) Welcome to Business Breakdowns (00:04:51) Understanding the US Healthcare System (00:10:24) UnitedHealth Group's Origins and Evolution (00:13:41) UnitedHealth Group's Business Model (00:22:36) Optum: The Overlooked Powerhouse (00:29:24) Value-Based Care: A New Approach (00:34:51) Current State of US Healthcare System (00:36:49) Regulatory Scrutiny and Media Attention (00:37:27) Investor Concerns and Company Response (00:42:49) Structural vs. Cyclical Issues (00:48:42) UnitedHealth's Technological Edge (00:52:07) Political Risks and Regulatory Environment (00:57:16) Medicare Advantage: A Closer Look (01:02:02) Lessons from UnitedHealth's Strategy

In this episode, host Mark Longo is joined by co-hosts "Uncle Mike" Tosaw from St. Charles Wealth Management and Andrew "the Rock Lobster" Giovanazzi from Option Pit. They discuss various aspects of the current options market, including unusual activity alerts, market analysis, and strategies. The show kicks off with a lively and contentious eighties trivia challenge, setting a spirited tone for the episode. Key topics include a detailed look at the AI phenomenon affecting tech stocks like Google Class A, Amazon, and Nvidia. They also delve into specific trades in stocks like UnitedHealth and their broader implications. Uncle Mike discusses the importance of having a plan when dealing with high-volatility trades and explains his cautious approach despite being a noted bull. The episode finishes with a preview of upcoming earnings, including household names like Dollar General and Cracker Barrel, and a thorough examination of ongoing options activity. 00:00 Introduction and Podcast Information 01:25 Meet the Hosts 03:13 80s Trivia Challenge 07:26 Market Analysis and Trading Insights 09:22 Drone Stocks and Market Reactions 15:20 Energy and Technology Sector Highlights 19:24 VIX and Single Stock Options Activity 25:44 Tech Stocks Performance Overview 26:09 Meta's AI Announcement and Market Reaction 26:52 Core Weave Deal and AI Dominance 27:47 Apple and Other Tech Giants 28:43 Palantir vs. Nvidia: A Market Poll 29:59 Earnings Highlights and Market Trends 31:24 Unusual Options Activity: The Odd Block 44:01 Strategy Insights: Hedging and Market Volatility 49:18 Market Watch and Final Thoughts  

In this episode, host Mark Longo is joined by co-hosts "Uncle Mike" Tosaw from St. Charles Wealth Management and Andrew "the Rock Lobster" Giovanazzi from Option Pit. They discuss various aspects of the current options market, including unusual activity alerts, market analysis, and strategies. The show kicks off with a lively and contentious eighties trivia challenge, setting a spirited tone for the episode. Key topics include a detailed look at the AI phenomenon affecting tech stocks like Google Class A, Amazon, and Nvidia. They also delve into specific trades in stocks like UnitedHealth and their broader implications. Uncle Mike discusses the importance of having a plan when dealing with high-volatility trades and explains his cautious approach despite being a noted bull. The episode finishes with a preview of upcoming earnings, including household names like Dollar General and Cracker Barrel, and a thorough examination of ongoing options activity. 00:00 Introduction and Podcast Information 01:25 Meet the Hosts 03:13 80s Trivia Challenge 07:26 Market Analysis and Trading Insights 09:22 Drone Stocks and Market Reactions 15:20 Energy and Technology Sector Highlights 19:24 VIX and Single Stock Options Activity 25:44 Tech Stocks Performance Overview 26:09 Meta's AI Announcement and Market Reaction 26:52 Core Weave Deal and AI Dominance 27:47 Apple and Other Tech Giants 28:43 Palantir vs. Nvidia: A Market Poll 29:59 Earnings Highlights and Market Trends 31:24 Unusual Options Activity: The Odd Block 44:01 Strategy Insights: Hedging and Market Volatility 49:18 Market Watch and Final Thoughts  

Aktien hören ist gut. Aktien kaufen ist besser. Bei unserem Partner Scalable Capital geht's unbegrenzt per Trading-Flatrate oder regelmäßig per Sparplan. Alle weiteren Infos gibt's hier: scalable.capital/oaws. Aktien + Whatsapp = Hier anmelden. Lieber als Newsletter? Geht auch. Das Buch zum Podcast? Jetzt lesen.  Baby Shark geht an Börse. BYD geht klein nach Japan. Meta geht zurück zu Palmer Luckey. Mai war geil für DAX, NASDAQ, S&P 500 und Michael O'Leary. Nur Regeneron, Eli Lilly & UnitedHealth leiden. Sonst so: GAP, Costco & Ulta mit Zahlen. Mit Evotec (WKN: 566480) konnte man sein Vermögen schonmal verhundertfachen. In den letzten Jahren hat man's eher vernichtet. Wie erklären, wie der Turnaround klappen soll. 70 Milliarden an verwaltetem Vermögen und mehr als 10% Rendite pro Jahr. Marshall Wace macht's möglich. Obwohl sich die zwei Gründer noch nie einig waren. Durch KKR (WKN: A2LQV6) kann man sogar investieren. Diesen Podcast vom 02.06.2025, 3:00 Uhr stellt dir die Podstars GmbH (Noah Leidinger) zur Verfügung.

JCO Editorial Fellow Dr. Lauren Shih and JCO Associate Editor Dr. Stephanie Wheeler discuss the ASCO 25 Simultaneous Publication paper "Use of Low-Value Cancer Treatments in Medicare Advantage Versus Traditional Medicare." Transcript The guest on this podcast episode has no disclosures to declare. Dr. Lauren Shih: Hello, and welcome to our 2025 ASCO annual meeting series where we cover some of the top JCO papers published simultaneously with their abstract presentations at this year's meeting. I'm your host, Dr. Lauren Shih, JCO editorial fellow, and I'm joined by JCO Associate Editor Dr. Stephanie Wheeler to discuss the Journal of Clinical Oncology article and abstract presentation "Use of Low-Value Cancer Treatments in Medicare Advantage Versus Traditional Medicare." Let's start with the relevance of the article. Dr. Wheeler, can you explain this to our listeners? Dr. Stephanie Wheeler: Thank you so much. Let's get right into it. So this article is really about understanding different types of Medicare plans and what we should expect to see in terms of their use of low-value treatments for cancer patients. So, as Medicare really is focused on trying to limit the use of low-value cancer treatments, we really need to better understand the drivers of variability. So we know that many cancer patients have multiple treatment options available to them. We also know that the vast majority of older adults beyond age 65 are insured by Medicare, and about half of them are on Medicare Advantage plans, which are serviced by private insurance. And private insurance companies in this case are receiving capitated payments for Medicare beneficiaries to manage their service utilization and reduce costs. So, with respect to Medicare Advantage versus the traditional fee-for-service Medicare, it's not really been known to what extent low-value treatments are differentially used by these types of plans for cancer patients. And so that was really the focus of this article. What the authors found is that across six different types of treatments, in general, the folks who were enrolled in Medicare Advantage plans had reduced use of low-value treatment. So that's a good sign for Medicare beneficiaries. And although the relative difference in that use was somewhat low, this translates to a significant number of Medicare enrollees across the country not receiving these low-value treatments. And of course, this translates to considerable savings at the society level. Dr. Lauren Shih: Are there any additional key results that we should review? Dr. Stephanie Wheeler: Yeah. So I'll tell you just a little bit more about the methods and also their findings. So they looked at six different low-value treatments, and this was in, again, 100% of national Medicare enrollees from 2015 through 2021. So the six low-value treatments that they examined were the use of G-CSFs among patients receiving low-risk chemotherapy and denosumab for those who had castration-sensitive prostate cancer. Then they also looked at four high-cost treatments, including using nab-paclitaxel instead of paclitaxel for patients with breast or lung cancer; second, adding bevacizumab to carboplatin plus paclitaxel for ovarian cancer; third, using brand-name drugs instead of generics when generics were available; and fourth, using biologics instead of biosimilars when biosimilars were available. And these are all, by the way, non-recommended treatments according to a variety of guidelines, including NCCN and ASCO's Choosing Wisely guidelines. So they used the Medicare claims data to examine use of these regimens. They also analyzed results by type of Medicare Advantage plan, whether people were enrolled in a health maintenance organization plan, or an HMO, or a preferred provider organization plan, or a PPO. They also looked at the largest Medicare Advantage insurers—including Aetna, Blue Cross Blue Shield, Cigna, Humana, and UnitedHealth—and limited their analyses to those that had complete encounter data. And what they found across the board is that the enrollees in Medicare Advantage plans generally had lower use of these low-value treatments. And the largest differences between Medicare Advantage and traditional Medicare plans were in the outcomes, including G-CSF use and using denosumab for castration-resistant prostate cancer, and then the combination of bevacizumab, carboplatin, and paclitaxel versus carboplatin and paclitaxel. And all of these had a change in use ranging from about 19% change to 24% change in use. This is significant as a field as we look at ways in which different plan organization can influence use of treatments, particularly given the excess cost of cancer care. This is something we really want to pay attention to. So I'd encourage folks to look more closely at the results by treatment type as well as the results by plan type to see a little bit more about what was going on across different plan types. Dr. Lauren Shih: Great. And are there any outstanding questions that need to be answered? Dr. Stephanie Wheeler: Yes, there always are, of course. I think the study has several strengths that are worth noting. First, they have 100% of Medicare enrollees, so there's national coverage there, which is, you know, quite outstanding. They also use an appropriate choice of analysis to help deal with some of the selection. So they use inverse probability of treatment weights, and they control for practice and county indicators to try to get some realistic adjustment for the selection that happens in terms of how patients are enrolled in different Medicare Advantage versus traditional fee-for-Medicare plans. These statistical approaches are a good idea, but they are limited by the observed variables that we can use for these kinds of adjustments. And so any unobserved—confounding or any unobserved factors that would influence selection in these plans aren't going to be captured well. So preferences, for example, that patients may have about different types of plans when they're insuring themselves and their families may not be captured. Second, the data that are used are only encounter data from those plans with complete records. That may mean that smaller Medicare Advantage insurers or those that don't have as comprehensive records are not included. So this may not be reflective of their practice patterns. And then third, of course, this only looked at six different low-value cancer treatments. It remains to be seen whether this kind of finding extends to other types of low-value cancer treatments, and that's an opportunity for future study. Finally, I would say that we don't exactly know why these patterns exist. It could be that Medicare Advantage plans have different approaches to prior authorization. They could have more in-house quality control and management to really understand, among their population for whom they're receiving Medicare Advantage payments, to really look at care quality and assess Choosing Wisely guidelines. We don't know exactly how that's playing out. And so we need additional data to really figure out what's working here and what are opportunities for future policy and payment innovations that can further reduce low-value care. Dr. Lauren Shih: Great. Thank you so much, Dr. Wheeler, for speaking to us about the JCO article, "Use of Low-Value Cancer Treatments in Medicare Advantage Versus Traditional Medicare." We really appreciate your insights. Dr. Stephanie Wheeler: Thanks for having me. Dr. Lauren Shih: Join us again for the latest simultaneous publications from the ASCO 2025 Annual Meeting. Please take a moment to rate, review, and subscribe to all ASCO podcast shows at asco.org/podcasts. Until then, enjoy the rest of ASCO 2025. The purpose of this podcast is to educate and to inform. This is not a substitute for professional medical care and is not intended for use in the diagnosis or treatment of individual conditions. Guests on this podcast express their own opinions, experience, and conclusions. Guest statements on the podcast do not express the opinions of ASCO. The mention of any product, service, organization, activity, or therapy should not be construed as an ASCO endorsement.

UnitedHealth stand lange auf meiner Watchlist, gekauft habe ich sie dennoch nicht. Jetzt wirkt der Chart interessant, aber ist die Aktie auch ein Kauf? Meine Einschätzung dazu erfährst du im heutigen Podcast. Vereinbare jetzt dein kostenfreies Strategiegespräch: https://jensrabe.de/Q2Termin25 Aktien kann Jeder - jetzt testen: https://jensrabe.de/YTAKJ Optionen kann Jeder - jetzt testen: https://jensrabe.de/YTOKJ ALLE Bücher von Jens Rabe: https://jensrabe.de/buecherYT Nur für kurze Zeit. Solange der Vorrat reicht. Schau auf meinem Social Media-Kanälen vorbei: Instagram - https://www.instagram.com/jensrabe_official X - https://twitter.com/jensrabe_ Facebook - https://www.facebook.com/rabeacademy TikTok - https://www.tiktok.com/@jensrabeacademy Börsen-News https://jensrabe.de/Q2NewsYT25

️ New Episode of Black Talk Radio News: “UnitedHealth Lawsuit Exposes the Cruelty of For-Profit Healthcare” Hosted by Scotty Reid | Black Talk Media Project…

️ New Episode of Black Talk Radio News: "UnitedHealth Lawsuit Exposes the Cruelty of For-Profit Healthcare" Hosted by Scotty Reid | Black Talk Media Project In this episode, Scotty Reid breaks down the latest class action lawsuit filed by investors against UnitedHealth Group—the largest health insurer in the U.S.—and exposes the deeper issue that corporate media won't touch: the devastating harm of America's for-profit healthcare system. As investors cry over lost billions, millions of Americans suffer without adequate care. Scotty compares this capitalist healthcare nightmare with more humane, publicly funded models in countries like Cuba and China—where health is treated as a human right, not a business opportunity. This episode is a wake-up call and a call to action. Tune in for truth, context, and solutions rarely heard in mainstream media. ️ Real Talk. Real Issues. Real Solutions. Support independent Black media: BlackTalkRadioNetwork.com Listen, comment, and share! #BlackTalkRadio #UnitedHealth #ForProfitHealthcare #HealthcareJustice #CapitalismKills #ScottyReid #BlackMediaMatters #MedicareForAll #HealthIsAHumanRight #CubaHealthcare #ChinaHealthcare #PublicHealth #BlackPodcasts #HealthcareReform #ClassActionLawsuit #UnitedHealthGroup #PeopleOverProfits Your help keeps us producing independent Black media. Please consider donating to support our work! You can send donations via Cash App: $BTMProject, PayPal: https://www.paypal.com/donate?hosted_button_id=6RQCWRMAG3AG2 I appreciate your support!

US healthcare has more unproductive labor and more unstructured data than any other industry, making it both vulnerable to disruption from generative AI and especially unprepared for it.That's the provocative thesis of Eric Larsen, president of TowerBrook Advisors. In this episode, he joins host Steve Kraus to explain why generative AI is unlike any other technology we've seen—and why the $4.9 trillion healthcare sector is uniquely exposed.We cover:

In this episode, Jakob Emerson, Associate News Director at Becker's Healthcare, joins Scott Becker to unpack the stunning recent upheaval at UnitedHealth Group, from stock plummets and leadership shakeups to DOJ investigations.

Fidel and Bae have a fireside chat and read a few articles. names mentioned: John Conyers, Bernie Sanders, Debbie Dingell, RFK Jr., Dr. Oz, Casey Means, Luigi Mangione, Andrew Witty, Bryan Thompson. This is a public episode. If you would like to discuss this with other subscribers or get access to bonus episodes, visit www.marxismandmedicine.com

Jonathan Kanter (former DOJ Antitrust) and Martin Gaynor (Carnegie Mellon Professor and former FTC official) join The Capitol Forum to discuss their groundbreaking paper, The Rise of Healthcare Platforms. They explain how companies like UnitedHealth have evolved into sprawling conglomerates—combining insurer, provider, pharmacy, and PBM functions—and why this consolidation threatens both market competition and patient care.

(5/16/2025-5/23/2025) UnitedScam. Tune in.#applepodcasts⁠ ⁠#spotifypodcasts⁠ ⁠#youtube #amazon⁠ ⁠#patreon⁠patreon.com/isaiahnews

United Health Group is having a bad, bad time. Let us tell you the fascinating and frustrating reasons why the stock recently lost a whopping $200 BILLION in value. Give this video a thumbs up if you enjoyed it! And please leave us a comment! It helps us! DENVER we are coming for you. Get tix here: https://comedyworks.com/comedians/ben-emil-live Our PORTLAND VIDEO IS OUT! https://youtu.be/qX4pks0ASq8 Sign up to watch and support the show at https://benandemilshow.com ***LINK TO OUR DISCORD: https://discord.gg/CjujBt8g ***Subscribe to Emil's Substack: https://substack.com/@emilderosa ***Trade with Ben at https://tradertreehouse.com Our episode with *Kyla Scanlon*: https://youtu.be/cIHWkY35cuc Big Tech is out of ideas (ft. ED ZITRON): https://youtu.be/zBvVGHZBpMw Arguing with a millionaire (ft. Chris Camillo): https://youtu.be/1ZUWTkWV_MM We bought suits HERE: https://youtu.be/_cM1XqA9n2U __ ROCKET MONEY: Cancel your unwanted subscriptions and reach your financial goals faster with Rocket Money! Go to https://rocketmoney.com/baes today! MUD/WTR: Start your new morning ritual and get up to 43% off your @MUDWTR with code BAES at https://mudwtr.com/baes #mudwtrpod SHOPIFY: Turn your big business idea into reality with Shopify on your side! Sign up for your one dollar per month trial and start selling today at https://shopify.com/baes HIMS: Fellas! Keep your hair thick and full! Start your FREE online visit today at https://hims.com/baes __ This episode was edited by Connor Rousseau / @ conrad_roussrad Follow us on instagram! @ benandemilshow @ bencahn @ emilderosa Learn more about your ad choices. Visit podcastchoices.com/adchoices

Bobby and Jared discuss The Who retiring, United Health going through a crisis, the new Qatari Air Force One, Newark airport falling apart, doing more outside work around the house, and the new Whoop release.   Make sure you SUBSCRIBE to the show to stay up to date on the latest releases! You can also find the video show on YouTube by clicking here.   Make sure you check out LMNT electrolyte drink mix at drinklmnt.com! Use the following link to get a FREE variety pack with your first purchase! http://elementallabs.refr.cc/jaredmello    Thank you to our sponsor MoonBrew! Go to www.noonbrew.com/jaredmello for 10% off your entire purchase!   Thank you to our sponsor The Ice Pod! Go to www.podcompany.com and use our promo code: JARED10093 for $10 off your entire purchase!   Make sure you sign up with MyBookie.com to get all of your bets in. Use our promo code: SARCASMPOD to double your first deposit up to $1000

On today’s show: – Reflecting on the 5 year anniversary of the police murder of George Floyd. – The DOJ moves to scrap consent decrees requiring police reforms in Minneapolis and other cities. – Jeff Stein’s weekly Wednesday visit. – The Guardian reports that UnitedHealth secretly paid nursing homes to reduce hospital transfers – MN’s…

It's hump day and as it so happens technical hiccup day. But don't worry, we got some scotch tape and paperclips and have McGyvered this thing for now. Republicans in Congress are doing what they can to push their massive tax cut through reconciliation, and you'll never get who's gonna benefit from that (it's rich people). To make it happen, Republicans are now trying to sneak in cuts to Medicare. We talk first to Singrid Steinmetz, an ICU nurse and a member of the California Nurses Association, which represents nearly 2,200 at Long Beach Medical Center who will be striking tomorrow. Here's the contact info for LBMC in case you want to tell management there to support it's nurses: https://www.memorialcare.org/locations/long-beach-medical-center After that, we hear from The Guardian U.S. investigative reporter George Joseph about his stunning new piece out today about how United Health Care has secretly paid nursing homes that helped it gain Medicare enrollees and reduced hospitalizations: https://www.theguardian.com/us-news/2025/may/21/unitedhealth-nursing-homes-payments-hospital-transfers  In the Fun Half, Emma, Sam and Matt respond to Skelator look-alike Rick Scott trying to make the case for making cuts to Medicaid by arguing that if you want health care in America you should have to work for it. Steve Scalise is singing the same tune. Bernie went on Andrew Schulz's show and managed to get him and his bros to acknowledge the problem of inequality and the absurdity of being the only industrialized country in the world without guaranteed health care. Also, Andrew Cuomo talks to Bari Weiss about what's ailing Democratic-run cities and states (hint, he blames the left) and he seems to be pushing an Abundance™ style agenda. Become a member at JoinTheMajorityReport.com: https://fans.fm/majority/join Follow us on TikTok here!: https://www.tiktok.com/@majorityreportfm Check us out on Twitch here!: https://www.twitch.tv/themajorityreport Find our Rumble stream here!: https://rumble.com/user/majorityreport Check out our alt YouTube channel here!: https://www.youtube.com/majorityreportlive Gift a Majority Report subscription here: https://fans.fm/majority/gift Subscribe to the ESVN YouTube channel here: https://www.youtube.com/esvnshow Subscribe to the AMQuickie newsletter here: https://am-quickie.ghost.io/ Join the Majority Report Discord! https://majoritydiscord.com/ Get all your MR merch at our store: https://shop.majorityreportradio.com/ Get the free Majority Report App!: https://majority.fm/app Go to https://JustCoffee.coop and use coupon code majority to get 10% off your purchase! Check out today's sponsors: Shopify: Sign up for a $1/month trial period at shopify.com/majority Fast Growing Trees: Get 15% off your first purchase.  FastGrowingTrees.com/majority Follow the Majority Report crew on Twitter: @SamSeder @EmmaVigeland @MattLech @RussFinkelstein Check out Matt's show, Left Reckoning, on Youtube, and subscribe on Patreon! https://www.patreon.com/leftreckoning Check out Matt Binder's YouTube channel: https://www.youtube.com/mattbinder Subscribe to Brandon's show The Discourse on Patreon! https://www.patreon.com/ExpandTheDiscourse Check out Ava Raiza's music here! https://avaraiza.bandcamp.com/ The Majority Report with Sam Seder – https://majorityreportradio.com/

Carl Quintanilla, Jim Cramer and David Faber explored tocks falling and yields spiking in light of the Capitol Hill standoff surrounding President Trump's tax and spending cuts bill. Hear Cramer's take on the proposed legislation. David broke out highlights from his blockbuster interview with Elon Musk, including the Tesla CEO's comments on robotaxis. TJX and Lowe's joined the retail earnings parade along with Target, which saw shares slide on disappointing results and guidance -- the CEO's message on pricing and tariffs in the mix as well . Also in focus: UnitedHealth responds to a report which states the company is the subject of a Medicare fraud probe.  Squawk on the Street Disclaimer

Tesla a focus today after David's wide-ranging and rare interview with CEO Elon Musk: Carl Quintanilla, Morgan Brennan, and David Faber broke down key takeaways from the tape – from Robotaxis to Chinese competition – along with Musk's vision for the future. Plus: the Co-CEO of Waymo's reaction to Musk's claims Tesla's tech is safer… and more with one analyst who's arguing Waymo should be spun-off - along with Alphabet's other ancillary businesses - to unlock more shareholder value here.  On the broader markets front: a few key movers – Target, Coreweave, United Health, and more… The team discussed what's driving the moves – in addition to fresh consumer color from executives at Toll Brothers, and the latest out of Washington when it comes to President Trump's “Big Beautiful Bill”. Squawk on the Street Disclaimer

Republican divisions over changes to Medicaid — the federal health care program for poor, elderly and disabled Americans — are becoming the chief hurdle to getting President Trump's major tax, immigration and energy agenda through Congress. GOP lawmakers who represent swing districts insist they will not vote for any proposal that strips benefits. But conservatives are demanding deep cuts in spending and say restructuring Medicaid is one of the clearest ways to achieve that goal. Jimmy and Americans' Comedian Kurt Metzger discuss whether Republicans will be able to pass the bill despite the hits MAGA supporters on Medicait will take as a result. Plus segments on President Donald Trump dismantling corrupt ex-FBI head James Comey and the Justice Department's recent announcement of an investigation into fraud committed by UnitedHealth, the company formerly headed by slain CEO Brian Thompson. Also featuring Stef Zamorano and Mike MacRae. Plus a phone call from Gavin Newsom!

Follow the Prof G Markets feed: Apple Podcasts Spotify  Scott and Ed discuss why United Health's stock hit a five year low, Warner Bros. Discovery's latest move to rebrand Max, and Airbnb's foray into offering bookable services for travelers. They then break down earnings from Alibaba and Tencent, highlighting how the results signal the growing momentum of AI in China — and why they're feeling bullish on the country's tech sector. Finally, they dissect the GOP's proposed tax bill, explaining how it overwhelmingly favors the wealthiest Americans and threatens to accelerate wealth concentration across the country. Subscribe to the Prof G Markets newsletter  Order "The Algebra of Wealth," out now Subscribe to No Mercy / No Malice Follow the podcast across socials @profgpod: Instagram Threads X Reddit Follow Scott on InstagramFollow Ed on Instagram and X Learn more about your ad choices. Visit podcastchoices.com/adchoices

Simply Wall St Market Insights for the week ending 19th May 2025.To read the full article: ⁠

Which companies got a boost from the trade truce between the U.S. and China? And how did UnitedHealth shares respond to a week of bad news? Plus, what was the reaction to news of Dick's Sporting Goods acquisition of Foot Locker? Host Francesca Fontana discusses the biggest stock moves of the week and the news that drove them. Sign up for the WSJ's free Markets A.M. newsletter. Learn more about your ad choices. Visit megaphone.fm/adchoices

Which companies got a boost from the trade truce between the U.S. and China? And how did UnitedHealth shares respond to a week of bad news? Plus, what was the reaction to news of Dick's Sporting Goods acquisition of Foot Locker? Host Francesca Fontana discusses the biggest stock moves of the week and the news that drove them. Sign up for the WSJ's free Markets A.M. newsletter. Learn more about your ad choices. Visit megaphone.fm/adchoices

In this packed Friday edition of The Daily Herold, Jon Herold tackles the controversy around James Comey's now-deleted “8647” Instagram post, which the Trump administration is investigating as a potential call for assassination. Jon weighs the possible meanings, whether it was an actual coded threat or just another case of elite hubris, and reacts to Trump's own fiery response. Next, Herold dives into breaking developments within the FBI as Cash Patel reveals the agency is abandoning the Hoover Building and decentralizing operations across the U.S., a move Trump hinted at months earlier. He connects the dots between the shake-up and broader efforts to purge corruption, including the shutdown of the FBI's public corruption unit that once helped launch the Arctic Frost probe into Trump. Other highlights include UnitedHealth's dramatic collapse amid federal fraud investigations, Trump's post-Middle East warning to 150 countries about pending tariffs, and the ongoing GOP failure to pass the “Big Beautiful Bill.” Jon also covers the EU's Digital Services Act and the Trump administration's pushback against global censorship laws. Blending breaking news, geopolitical analysis, and unfiltered commentary, this episode captures the chaos and clarity of a movement reclaiming power one headline at a time.

TBOY Live Show Tickets to Chicago on sale NOW: https://www.axs.com/events/949346/the-best-one-yet-podcast-ticketsFoot Locker surged 80% on deal with Dick's… but the wilder story is Dick's sports palaces.Rainmaker got $30M to play God and make it rain (literally)... We got the history of human-made rain.UnitedHealth just had its worst month ever… And now it's made every health stock sick.Plus, why did Rihanna put caviar on chicken?... Because caviar is cheaper than ever.$FL $DKS $UNHWant more business storytelling from us? Check out the latest episode of our new weekly deepdive show: The untold origin story of… Subscribe to The Best Idea Yet: Wondery.fm/TheBestIdeaYetLinks to listen.About Us: The daily pop-biz news show making today's top stories your business. Formerly known as Robinhood Snacks, TBOY Lite is hosted by Jack Crivici-Kramer & Nick Martell.GET ON THE POD: Submit a shoutout or fact: https://tboypod.com/shoutouts NEWSLETTER:https://tboypod.com/newsletter SOCIALS:Instagram: https://www.instagram.com/tboypod TikTok: https://www.tiktok.com/@tboypodYouTube: https://www.youtube.com/@tboypod Anything else: https://tboypod.com/ Our 2nd show… The Best Idea Yet: Wondery.fm/TheBestIdeaYetLinksEpisodes drop weekly.See Privacy Policy at https://art19.com/privacy and California Privacy Notice at https://art19.com/privacy#do-not-sell-my-info.

Russia and Ukraine have sat down for their first talks since 2022, but hopes aren't high. A New Jersey Transit strike means rail commuters are being encouraged to work from home. There are concerns about an American aid organization making promises for Gaza. We'll tell you why NYU is withholding a student's diploma after his commencement speech. And, one of America's biggest companies is having a seriously bad week. Learn more about your ad choices. Visit podcastchoices.com/adchoices

Scott Wapner and the Investment Committee debate whether the rally has legs as stocks continue to rebound. Plus, multiple moves from the Investment Committee – they share the details of their latest trades. And later, UnitedHealth having a tough week, the desk debates how to trade the name from here.  Investment Committee Disclosures

Today, a blitz of news, from geopolitics on latest trade deal developments and more, to specific company news, particularly United Health and Meta, which faces possible major business risks that are perhaps underappreciated. Today's pod also covers the latest macro data, the big bounce in gold, the outlook for USD and JPY, huge tectonic issues for the US treasury market and more. Today's pod hosted by Saxo Global Head of Macro Strategy John J. Hardy. Michael McNair post on X mentioned on the pod. John's latest FX Update.    Read daily in-depth market updates from the Saxo Market Call and SaxoStrats Market Strategy Team here. Please reach out to us at marketcall@saxobank.com for feedback and questions. Click here to open an account with Saxo.

One of the biggest media mergers in years just dropped, but will it make it past federal regulators? Plus, eToro is wrapping up its first week as a public company as several other companies lay out their IPO plans. Is it a positive sign for the IPO pipeline? And UnitedHealth has been hammered since Monday, for its worst week since 2009, but could now be the buying opportunity of a lifetime? We'll debate.

Unlimited CEO Bob Elliot and Truist Wealth's Keith Lerner break down the macro setup in the market panel, while CNBC's Kate Rooney reports on why Main Street is continuing to buy the dip.John San Marco of Neuberger Berman weighs in on retail earnings and a resilient consumer. Deutsche Bank's George Hill makes a case for sticking with UnitedHealth despite its drawdown this week. Plus, our Robert Frank reports on the future of the estate tax, and Morgan Brennan highlights $17B space company Trimble for this week's Manifest Space.  

God's Debris: The Complete Works, Amazon https://tinyurl.com/GodsDebrisCompleteWorksFind my "extra" content on Locals: https://ScottAdams.Locals.comContent:Politics, Adam Corolla, Malibu Fires Rebuilding Standards, Kamala Harris Social Training, Gavin Newsom Rebranding, Alpha School AI Training, President Biden's Memory, President Trump, Trump's Middle East Speech, Western Intervention Failures, Qatar Camel Quality, President Trump's Aura, Qatar Conflict Mediation, Iran Nuclear Deal, Iran's Terrorist Funding, Tulsi Gabbard, NIC Firings, John Brennan, SCOTUS Universal Injunctions, Climate Activists, Greta Thunberg, Derek Chauvin Possible Pardon, United Health, Rogue Communication Devices, Slate Electric Truck, Scott Adams~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~If you would like to enjoy this same content plus bonus content from Scott Adams, including micro-lessons on lots of useful topics to build your talent stack, please see scottadams.locals.com for full access to that secret treasure.

Carl Quintanilla, Jim Cramer and David Faber led off the show with reaction to Walmart's Q1 results -- and the company's CFO telling CNBC that the retail giant could raise prices later this month due to tariffs. Cisco CEO Chuck Robbins and CoreWeave CEO Michael Intrator joined the anchors at Post 9 to discuss their companies' respective quarterly results and the AI landscape. UnitedHealth shares slide again -- this time on a report stating the health insurer is under criminal investigation for Medicare fraud.  Also in focus: Foot Locker soars on its deal with Dick's Sporting Goods, a surprise drop in PPI, President Trump's "little problem" with Apple CEO Tim Cook. Squawk on the Street Disclaimer

Carl Quintanilla, Sara Eisen, and David Faber broke down the latest data from the AM (Retail Sales, PPI, and more) along with this move higher in yields. Former Fed Governor Frederic Mishkin arguing the Fed is “appropriately” on hold here – and the deficit remains a huge issue… While the CFO of Walmart brought his read from the ground when it comes to the consumer – and possible price hikes ahead.  Plus: key break-outs of the stocks to watch here. United Health shares plunging on reports it's the subject of a new DOJ probe – why Mizuho thinks it could get removed from the Dow… Coreweave shares falling on fears over their Cap-Ex plans but Melius Research argues the stock is still a buy… And a breakdown of the deal sending Foot Locker shares surging in what could be their best daily performance ever.  Squawk on the Street Disclaimer

In this episode, we break down the temporary 90-day tariff pause between the U.S. and China, what it could mean for markets, and why it might not last. We also dive into BCE’s massive dividend cut and new growth-focused partnership with PSP Investments. Plus, we unpack UnitedHealth’s stunning 50% drop in just over a month, Goeasy’s soft quarter and what it signals about the subprime lending landscape, and Franco-Nevada’s blowout results amid soaring gold prices. Tickers of stocks discussed: FNV.TO, GSY.TO, BCE.TO, UNH Check out our portfolio by going to Jointci.com Our Website Canadian Investor Podcast Network Twitter: @cdn_investing Simon’s twitter: @Fiat_Iceberg Braden’s twitter: @BradoCapital Dan’s Twitter: @stocktrades_ca Want to learn more about Real Estate Investing? Check out the Canadian Real Estate Investor Podcast! Apple Podcast - The Canadian Real Estate Investor Spotify - The Canadian Real Estate Investor Web player - The Canadian Real Estate Investor Asset Allocation ETFs | BMO Global Asset Management Sign up for Finchat.io for free to get easy access to global stock coverage and powerful AI investing tools. Register for EQ Bank, the seamless digital banking experience with better rates and no nonsense.See omnystudio.com/listener for privacy information.

This episode of The Option Block delves into recent trends in options markets, including a massive surge in volume during April and the notable activity in quantum computing stocks such as D-Wave Quantum. The discussion also covers the rise and fall of various sectors, key activities in names like American Eagle Outfitters and United Health, and the state of volatility in the markets. Additionally, the hosts engage the audience with polls on VIX trades and options strategies, discuss the unpredictable nature of the current market, and share insights from recent industry conferences.   03:15 Kickoff: The Option Block Show Begins 05:44 Market Overview and Trading Insights 07:57 Uncle Mike Tosaw's Market Observations 11:48 Kevin Carter's Market Analysis 14:32 April Options Market Performance from OCC 18:37 Zero-Day Options Trading 23:22 Single Name Stocks and Market Movers 29:05 Market Panic and Put Options Strategy 30:13 Tesla and Nvidia Stock Analysis 31:02 Hot Earnings Action This Week 33:22 The Odd Block: Unusual Options Activity 38:31 Quantum Computing Stocks: D-Wave Quantum Inc. 43:05 Open Door Technologies and Long-Term Calls 46:03 VIX Polls and Market Predictions 51:23 Around the Block: Market Leaders and Bonds  

The White House unveiled what it says is $600bn worth of defence and artificial intelligence deals with Saudi Arabia, UnitedHealth Group shares sink to the lowest level in more than four years, and US inflation fell to 2.3 per cent in April. Plus, Nissan plans to axe 15 per cent of its global workforce and almost halve its number of plants.Mentioned in this podcast:Donald Trump lauds Saudi Arabia as he unveils AI and defence dealsUnitedHealth chief Andrew Witty steps down as shares plungeUS inflation falls to 2.3% in April as tariff effect loomsNissan to axe 15% of global workforce and almost halve number of plantsToday's FT News Briefing was produced by Sonja Hutson, Kasia Broussalian, Lulu Smyth, and Marc Filippino. Additional help from Simon Panayi, Michael Lello, David da Silva and Gavin Kallmann. Topher Forhecz is the FT's co-head of audio. The show's theme song is by Metaphor Music.Read a transcript of this episode on FT.com Hosted on Acast. See acast.com/privacy for more information.

Scott Wapner and the Investment Committee discuss the markets run to new highs and how to navigate the move. Plus, we debate the latest calls of the day on Robin Hood, UnitedHealth, Abbvie and more. And later, the desk reveal their latest portfolio moves.  Investment Committee Disclosures

After Monday's big market rally fueled by the U.S.-China deal to temporarily slash tariffs, Carl Quintanilla, Jim Cramer and David Faber led offthe show with market reaction to the April Consumer Price Index and what it says about inflation. The anchors also discussed President Trump's trip to Saudi Arabia, where he greeted prominent CEOs including Jensen Huang and Elon Musk. Also in focus: UnitedHealth drags the Dow lowerafter the health insurer suspended its 2025 guidance and announced its CEO stepped down, Coinbase to join the S&P 500, Phillips 66-Elliott proxy fight. Squawk on the Street Disclaimer

Scott Wapner and the Investment Committee debate the next leg higher for stocks as new highs are in sight for the S&P. Plus, UnitedHealth hitting a new 52-week low, it's our Chart of the Day. And later, Josh Brown shares a new stock addition to his best stock in the market group.  Investment Committee Disclosures

Stocks edge higher as the S&P 500 gains a high-profile new member: Coinbase. Phil Camporeale of J.P. Morgan breaks down the market action, while Supermicro's AI positioning draws fresh Wall Street attention—Raymond James' Simon Leopold explains his bullish call. CyberArk CEO Matt Cohen joins to discuss earnings, enterprise IT spend and security sector consolidation while Saira Malik of Nuveen shares where she's seeing new opportunity in equities and fixed income.   Our Bertha Coombs tracks UnitedHealth's rough day, Eamon Javers reports on the president's visit to Saudi Arabia alongside high-profile American CEOs. Plus, Michael Santoli's dashboard signals a return of risk-on sentiment and what it means for Coinbase to be added to the S&P 500 and Robert Frank spots cracks in the high-end art market.